EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Determinants of Treatment Failure and Safety Profile of Extracorporeal Shock Wave Lithotripsy for Upper Urinary Tract Stones: A Secondary Analysis of a Retrospective Cohort of 941 Patients With Risk Stratification and Decision Curve Analysis

Tariq Aziz Alaqrawi

Health Innovation Reports · 2026-04-15 · 2 (2) · 4-17

DOI: 10.64048/hir.v2n2.002 ↗
AbstractBibliografische Angaben

Abstract

Background and aim: Extracorporeal shock wave lithotripsy (ESWL) remains a widely used non-invasive treatment for upper urinary tract stones, yet many patients experience treatment failure, retreatment, auxiliary procedures or complications. This study identified their determinants and developed a simple risk-stratification tool evaluated with decision curve analysis.Methods: This secondary analysis of a publicly archived retrospective cohort included 941 patients treated with piezoelectric ESWL for renal or proximal ureteral stones at a single centre (2018–2023). Treatment failure was defined as residual fragments larger than 4 mm at three months. Hierarchical multivariable logistic regression, bootstrap internal validation and decision curve analysis were employed.Results: Stone clearance was achieved in 734 patients (78.0%), whereas 207 (22.0%) experienced treatment failure; 178 (18.9%) needed retreatment, 97 (10.3%) required an auxiliary procedure and 47 (5.0%) developed complications. Stone size greater than 10 mm predicted failure (adjusted odds ratio [aOR] = 1.52), and density above 739 Hounsfield units predicted retreatment (aOR = 1.77). Skin-to-stone distance (aOR = 1.21 per cm) and pre-ESWL double-J stenting (aOR = 2.49) predicted auxiliary procedures, while anticoagulant therapy (aOR = 6.06), hypertension (aOR = 3.78) and female sex (aOR = 2.17) predicted complications. A four-item stone score stratified composite unfavourable outcomes from 31.6% to 58.3%, with modest discrimination (optimism-corrected AUC = 0.578).Conclusions: Stone-related characteristics determined ESWL efficacy, whereas anticoagulant therapy, hypertension and female sex determined its safety. A simple stone score can support pre-treatment counselling, but external validation is required before it guides treatment selection.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →